Pennsylvania NY NJ Biotech Networks Breaking News Headlines Today

Pennsylvania NY NJ Biotech Networks

See all of Pennsylvania NY NJ Biotech Networks news coverage in one place. Discover how Pennsylvania NY NJ Biotech Networks’s media bias informs their coverage and compare with thousands of other news outlets.

In total, 1,382 have been published by Pennsylvania NY NJ Biotech Networks which Ground News has aggregated in the past 3 months.

We’ve assigned a media bias rating of unknown to Pennsylvania NY NJ Biotech Networks. You can read more about our methodology here.

Is Pennsylvania NY NJ Biotech Networks credible or reliable? Our Factuality score answers both of those questions. When it comes to Pennsylvania NY NJ Biotech Networks, we’ve assigned a unknown factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check.

Information about Pennsylvania NY NJ Biotech Networks

Where is Pennsylvania NY NJ Biotech Networks located?Pennsylvania NY NJ Biotech Networks's Website

Factuality

How credible is the news from Pennsylvania NY NJ Biotech Networks?

Unknown

by Ad Fontes Media and Media Bias/Fact Check

Learn more about Factuality Ratings.

Media Bias Ratings

Does Pennsylvania NY NJ Biotech Networks lean left or right?

Learn more about Media Bias Ratings.

Top Pennsylvania NY NJ Biotech Networks News

Cancer · New York

Pfizer inks $43 billion Seagen deal to boost cancer portfolio

50% Center coverage: 85 sources

Pfizer Inc on Monday struck a roughly $43 billion deal for Seagen Inc to bulk up its cancer treatment portfolio, as the drugmaker braces for a steep fall in COVID-19 product sales and loss of exclusivity for some top sellers.See the Story

Medical · Pennsylvania

New Research in JNCCN Highlights the Negative Impact of Continued Exclusion of Racial Groups from Research on Cancer Genomics

Lack of genomic research for people with African ancestry is hampering efforts to reduce disparities in cancer care. In a first-of-its-kind study, researchers evaluated molecular genetic results for 113 Black South African men diagnosed with advanced prostate cancer. The researchers found 38 mutations across 52 patients. A total of 17 pathogenic (4) and potential oncogenic (13) variants were identified.See the Story

Who and what you missed at the ABR’s Health Care Power Breakfast – Pennsylvania NY NJ Biotech Networks

See the Story

Latest News Stories

Pennsylvania · Pennsylvania

Industry advocates urge Senate health committee leaders to support antimicrobial pricing reform – Pennsylvania NY NJ Biotech Networks

A long list of drugmakers and industry organizations has come together in the hopes of once again bringing antimicrobial resistance to lawmakers’ attention. The group penned a letter to Sens. Bernie Sanders (I-VT) and Bill Cassidy (R-LA), chair and ranking member of the Senate Committee on Health, Education, Labor andSee the Story

FDA · New Jersey

FDA inspection uncovers cherry-colored antibiotic residue on equipment at Teva’s New Jersey site – Pennsylvania NY NJ Biotech Networks

An FDA inspection report on Teva’s manufacturing site in New Jersey has revealed issues with both equipment cleaning and quality. The three-page report, which was obtained by Endpoints News via a FOIA request from the FDA, showed several observations f... [...]See the Story

FDA · Pennsylvania

Pharmalittle: FDA head wants to get rid of advisory panel votes; premature-birth drug is finally withdrawn

100% Center coverage: 1 sources

The U.S. Food and Drug Administration commissioner would like to get rid of voting at the end of advisory committee meetings. While you ponder the possibilities, we invite you to join us for a delightful cup of stimulation. Our choice today is caramel apple, a sweet treat.See the Story